Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuoqing San for Wound Healing After Anal Fistula Surgery
NCT07128953Phase 1Enrolling by invitation
- Start
- Aug 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anal fistula comparing Zuoqing San Group with Placebo Group (2 arms). Primary endpoint: Wound healing time up to 8 weeks. Started Aug 2025; status: enrolling by invitation.
02
Drugs
Zuoqing San
03
Conditions
anal fistula
Beyond the preview
Go deeper on NCT07128953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07128953.